Faculty Opinions recommendation of Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study.
Keyword(s):
Phase Ii
◽
2017 ◽
Vol 24
(2)
◽
pp. 316-325
◽